| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |